Retreatment of hepatitis C non-responsive to Interferon. A placebo controlled randomized trial of Ribavirin monotherapy versus combination therapy with Ribavirin and Interferon in 121 patients in the Benelux [ISRCTN53821378]

Autor: Veldt, Bart B.J., Brouwer, Johannes J.T., Adler, Michael, Nevens, Frederik, Michielsen, Peter, Delwaide, Jean, Hansen, Bettina, Schalm, Solko Walle, van Berge Hanegouwe, G.P., Bourgeois, Nadine, Brouwer, Johannes, Buydens, Peter, Chamuleau, Robert Afm, Ditzhuysen, Th J M, Elewaut, André, Fevery, Johan, Fierens, Herbert, De Galocsy, Chantal, Van Hattum, Jan, Hautekeete, Marc Leopold, van Hoek, Bart, Mulder, Chris Jacob Johan, de Ouden-Muller, J.W., Reesink, Hendrik, Schalm, S.W., Tuynman, Hans, Versieck, H., Van Vlierberghe, Hans, De Vries, Richard, Weegink, Christine J.

Publikováno v: BMC Gastroenterology
BMC Gastroenterology, 3, 24-33. BioMed Central Ltd.
BMC Gastroenterology, Vol 3, Iss 1, p 24 (2003)
BMC gastroenterology, 3

Background: Evidence based medicine depends on unbiased selection of completed randomized controlled trials. For completeness it is important to publish all trials. This report describes the first large randomised controlled trial where combination t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dbcc9566e54a66fa8dcc1fcc6f1effd
http://europepmc.org/articles/PMC222984